spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Genomic Profiling 

 HSMN NewsFeed - 21 Nov 2024
SOPHiA GENETICS Launches MSK-IMPACT(R) powered with SOPHiA DDM(TM) at AMP 2024
Diagnostics Product Launch
 HSMN NewsFeed - 25 Apr 2023
Strata Oncology Announces Launch and Medicare Coverage for Strata Select, a First-of-its-kind Immunotherapy Test
Diagnostics Oncology Product Launch Reimbursement
 HSMN NewsFeed - 25 Mar 2022
Roche announces collaboration with Bristol Myers Squibb to advance personalised healthcare through digital pathology solutions
Diagnostics
 HSMN NewsFeed - 15 Dec 2021
Roche Launches the First Infectious Disease Tests and Cobas Omni Utility Channel for Use on the Cobas 5800 System in Countries Accepting the CE Mark
Diagnostics Product Launch
 HSMN NewsFeed - 29 Nov 2021
Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 7 Oct 2021
SAGA Diagnostics appoints Peter Collins as Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 28 Jul 2021
Strata Oncology Completes $90 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 19 Apr 2021
Amgen Launches Biomarker Assist(TM), a Program To Help More Patients With Non-Small Cell Lung Cancer Gain Access To Biomarker Testing
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 21 Oct 2020
MammaPrint(R) Approved for Reimbursement in Germany
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 22 Jun 2020
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 11 Feb 2020
Novartis announces MET inhibitor capmatinib (INC280), the first potential treatment for METex14 mutated advanced non-small cell lung cancer, granted priority FDA review
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Jan 2020
Breast Cancer Patients in Germany Now have Insurance Coverage for MammaPrint(R) Testing through Techniker Krankenkasse
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 11 Dec 2019
Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Genomic Profiling Similarity Score
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 21 Nov 2019
Biocept Announces the Launch of its Liquid Biopsy Test to Detect TRK Biomarkers in the Blood of Patients Diagnosed with Cancer
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 3 May 2019
Caris Life Sciences Receives FDA Breakthrough Device Designation for MI Transcriptome(TM) Companion Diagnostic Test
Diagnostics Oncology FDA
 HSMN NewsFeed - 7 Jan 2019
Lilly Announces Agreement To Acquire Loxo Oncology
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 23 Nov 2018
Precision Oncology Company Guardant Health AMEA announces launch of its Asia, Middle East and Africa regional headquarters in Singapore
Diagnostics Oncology
 HSMN NewsFeed - 26 Jun 2018
Caris Life Sciences Expands Management Team
Diagnostics Personnel
 HSMN NewsFeed - 21 Jun 2018
Caris Life Sciences Presents Data Demonstrating the Ability of ADAPT Biotargeting System to Identify Responders and Non-Responders in a Phase III Pancreatic Cancer Study
Diagnostics Oncology
 HSMN NewsFeed - 23 Mar 2018
Caris Life Sciences Announces Published Results Showing that its ADAPT Biotargeting System Effectively Stratified Breast Cancer Patients Based on Their Benefit from Trastuzumab Treatment (Herceptin)
Biopharmaceuticals Diagnostics Oncology
 HSMN NewsFeed - 19 Sep 2017
Esteemed Researcher and Clinical Oncologist W. Michael Korn, M.D. Joins Caris Life Sciences as Chief Medical Officer
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 17 May 2017
Caris Life Sciences Appoints John Marshall, M.D., as Chief Medical Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 20 Dec 2016
Foundation Medicine Receives FDA Approval of FoundationFocus(TM) CDxBRCA as a Companion Diagnostic for Rubraca(TM) (rucaparib) for the Treatment of Women with Ovarian Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 13 Jul 2016
Second Genome Appoints Glenn Nedwin, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2016
ACT Genomics Raises $12.5 Million In Series B Funding
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 1 Jul 2015
Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product
Diagnostics Oncology Personnel
 HSMN NewsFeed - 2 Oct 2012
Cell Therapeutics OPAXIOTM Receives Orphan Drug Designation for Malignant Brain Cancer from FDA
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Sep 2012
Foundation Medicine Announces $42.5 Million Series B Financing
Personalized Medicine Oncology Venture Capital
 HSMN NewsFeed - 15 Dec 2007
Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Feb 2007
PDL BioPharma Announces New Chief Medical Officer and Appoints Chief Scientific Officer to Its Board of Directors
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 2 additional stories matching:
Genomic Profiling
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.